Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this phase I/II trial is to evaluate safety and tolerability of a single dose of GHB16L2 administered by liquid nasal spray for vaccination against seasonal influenza virus infection. It is also performed to assess immunogenicity and pharmacokinetics (shedding).
Epistemonikos ID: d8bf766095580045b486e9d64d6886c364ca39a7
First added on: May 06, 2024